Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › VolitionRx Plans Partnership to Launch Cancer Dx Platform in China

VolitionRx Plans Partnership to Launch Cancer Dx Platform in China

Mar 28, 2019
|
staff reporter

NEW YORK (360Dx) — Belgian diagnostics firm VolitionRx announced today that it is planning a partnership with Shanghai Fosun Long March Medical Science to introduce its NuQ blood-based cancer diagnostic platform in China.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Featured Webinar

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.

What's Popular?

In Cancer

  1. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

  2. Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

  3. Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

  4. Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

    Premium

  5. UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.